- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 07.11. | Sona Nanotech Inc.: Sona Nanotech to Showcase Its THT Cancer Therapy at NCL 20th Anniversary Symposium and Provides Corporate Update | 333 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - November 7, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to announce that its Chief Scientific Officer, Dr. Len Pagliaro... ► Artikel lesen | |
| 21.10. | Sona Nanotech Inc: Sona receives U.S. patent for gold nanorod process | 1 | Stockwatch | ||
| 21.10. | Sona Nanotech Inc.: Sona Nanotech Issued Patent and Appoints New Board Member | 436 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - October 21, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to announce the issuance of U.S. Patent No. 12117447 by... ► Artikel lesen | |
| 09.10. | Sona Nanotech Inc: Sona Nanotech grants option to buy 25,000 shares | 1 | Stockwatch | ||
| 09.10. | Sona Nanotech Inc.: Sona Nanotech Grants Options | 391 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - October 9, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona") is pleased to announce that it has granted 25,000 incentive stock... ► Artikel lesen | |
| SONA NANOTECH Aktie jetzt für 0€ handeln | |||||
| 24.09. | Sona Nanotech Inc: Sona Nanotech closes $1.64-million private placement | 3 | Stockwatch | ||
| 24.09. | Sona Nanotech Inc.: Sona Nanotech Closes Private Placement Financing to Raise $1,643,750 in Gross Proceeds | 570 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - September 24, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona") is pleased to announce that it has closed its non-brokered private... ► Artikel lesen | |
| 05.09. | Sona Nanotech Inc: Sona Nanotech closes $1.5-million private placement | 1 | Stockwatch | ||
| 05.09. | Sona Nanotech Inc.: Sona Nanotech Closes Private Placement Financing to Raise $1,500,000 in Gross Proceeds and Announces Additional Financing | 660 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - September 5, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona") is pleased to announce that it has closed its non-brokered private... ► Artikel lesen | |
| 31.07. | Sona Nanotech Inc: Sona Nanotech arranges $1.5-million private placement | 2 | Stockwatch | ||
| 31.07. | Sona Nanotech Inc.: Sona Nanotech to Arrange Private Placement Financing | 565 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - July 31, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to announce that it plans to raise up to $1,500,000 through... ► Artikel lesen | |
| 26.06. | Sona Nanotech Inc.: Sona's Cancer Therapy Triggers Abscopal Effect, Eliminating Distant Tumors In Preclinical Melanoma Study | 632 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - June 26, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona") is pleased to announce that a detailed biomarker analysis of the recently... ► Artikel lesen | |
| 20.06. | Sona Nanotech Inc: Sona talks THT results in preclinical melanoma model | 1 | Stockwatch | ||
| 20.06. | Sona Nanotech's therapy shines in cancer trials | 1 | The Market Herald Canada | ||
| 20.06. | Sona Nanotech Inc.: Sona's Therapy Shows Significant Preclinical Efficacy in Second Cancer | 615 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - June 20, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona") is pleased to announce that its targeted hyperthermia therapy ("THT")... ► Artikel lesen | |
| 21.05. | Sona Nanotech Inc.: Sona Appoints Chief Medical Officer and Files Provisional Conjugation Patent | 684 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - May 21, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona") is pleased to advise that it has appointed Dr. Carman Giacomantonio MD... ► Artikel lesen | |
| 29.04. | Sona Nanotech Inc.: Sona's Cancer Therapy Creates a Systemic Immune Response in Murine Breast Cancer Model | 748 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - April 29, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona") announces further results from the triple negative breast cancer murine... ► Artikel lesen | |
| 12.04. | Sona Nanotech Inc.: Sona Nanotech Provides Interim Results of Dalhousie Efficacy Study | 697 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - April 12, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona") is pleased to announce further positive interim results from its study... ► Artikel lesen | |
| 08.04. | Sona Nanotech Inc.: Sona Nanotech Secures Grant Funding to Support Intellectual Property Strategy and Development | 700 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - April 8, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona") announces that it has been approved for funding totaling approximately... ► Artikel lesen | |
| 25.03. | Sona Nanotech Inc.: Sona Nanotech Updates on Dalhousie Efficacy Study and New NCL Results | 552 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - March 25, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona") announces positive interim results from its study with The Giacomantonio... ► Artikel lesen |
Seite:
1 2 Weiter >>
24 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FORMYCON | 46,850 | +0,75 % | EQS-News: Formycon AG: Formycon erhält positive CHMP-Empfehlung für FYB203 (Aflibercept), einen Biosimilar-Kandidaten für Eylea®, unter den Markennamen AHZANTIVE® und Baiama® | EQS-News: Formycon AG
/ Schlagwort(e): Stellungnahme/Zulassungsantrag
Formycon erhält positive CHMP-Empfehlung für FYB203 (Aflibercept), einen Biosimilar-Kandidaten für Eylea®... ► Artikel lesen | |
| NANOPHASE TECHNOLOGIES | - | - | Nanophase Technologies Corporation: Nanophase Reports Record Third Quarter Revenue and Profit | -Nanophase Reports Q3 Revenue Record at $16.9 Million with Solésence Revenue up 171% YOY? -Record $3 Million in Q3 Profit ROMEOVILLE, Ill., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Nanophase Technologies... ► Artikel lesen | |
| VEECO INSTRUMENTS | 26,200 | -0,76 % | Veeco-Aktie fällt auf 52-Wochen-Tief von 25,68 US-Dollar | ||
| KOPIN | 0,964 | -0,10 % | Kopin Corp Q3 Loss Increases, But Beats Estimates | WASHINGTON (dpa-AFX) - Kopin Corp (KOPN) reported Loss for its third quarter that increased from last year but beat the Street estimates.The company's earnings came in at -$3.46 million, or... ► Artikel lesen | |
| ONTO INNOVATION | 158,00 | -1,25 % | Finanzvorstand von Onto Innovation verkauft Aktien im Wert von 176.451 US-Dollar | ||
| NANOFORM FINLAND | 1,398 | +1,45 % | Nanoform Finland Oyj: Nanoform Q3 2024 report: Record number of new projects signed | Company Announcement
Nanoform Finland Plc
November 18, 2024
08:10 a.m. Finnish time / 07:10 a.m. Swedish time
Nanoform Q3 2024 report: Record number of new projects signed
A record number of new... ► Artikel lesen | |
| NANOFOCUS | 1,310 | 0,00 % | NanoFocus passt Prognose für 2024 an | Die NanoFocus AG hat heute beschlossen, die Prognose für das laufende Jahr anzupassen. Aufgrund von gegenwärtig absehbar deutlich niedrigeren Umsätzen in den Bereichen Semiconductor Asia und Standard/Labor... ► Artikel lesen | |
| GAUZY | 8,000 | +3,90 % | CEO interview: Eyal Peso, Gauzy | ||
| ACACIA RESEARCH | 4,180 | -0,95 % | Acacia Research Reports Third Quarter 2024 Financial Results | NEW YORK--(BUSINESS WIRE)--Acacia Research Corporation (Nasdaq: ACTG) ("Acacia" or the "Company"), which acquires and operates businesses across the industrial, energy and technology sectors, today... ► Artikel lesen | |
| ADVANCE ZINCTEK | 0,442 | 0,00 % | ADVANCE ZINCTEK LIMITED: Change of Director's Interest Notice - Lev Mizikovsky | ||
| LEHNER INVESTMENTS | 0,015 | 0,00 % | EQS-DD: LEHNER INVESTMENTS AG: RIMIVY LTD, Verkauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
05.07.2024 / 16:36... ► Artikel lesen | |
| RIBER | 2,500 | 0,00 % | RIBER: Solid Business Growth at End-September 2024 | SOLID BUSINESS GROWTH AT END-SEPTEMBER 2024 Revenues up +14% to €18.5mOrder book strengthened to €38.3m (+14%) Bezons, October 30, 2024 - 8:00am - RIBER, the global leader for molecular beam epitaxy... ► Artikel lesen | |
| NANOVIRICIDES | 1,150 | -5,74 % | NanoViricides, Inc. Has Filed Its Quarterly Report: Broad-spectrum Antiviral NV-387 Progressing to Phase II Clinical Trial - Multiple Indications of NV-387 Include MPOX/Smallpox, RSV, Influenza, COVID | SHELTON, CT / ACCESSWIRE / November 15, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), reports that it has filed its Quarterly Report on Form 10-Q for the quarter ending September... ► Artikel lesen | |
| GOMSPACE | 0,358 | +4,22 % | GOMSPACE A/S: ESA and GomSpace sign 8.4 MSEK contract change notice for the GOMX-5 project | ||
| REGION GROUP | 1,300 | +1,09 % | REGION GROUP: Initial Director's Interest Notice |
Das Unternehmen SONA NANOTECH INC kann der Branche Nanotechnologie zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SONA NANOTECH INC finden Sie auf Wallstreet Online.
